Investing.com -- Shares of Rumble Inc. (NASDAQ: RUM) rose 24% following the release of the company’s first-quarter earnings, which surpassed analysts’ estimates. The video-sharing platform reported a ...

Shares of Onto Innovation Inc. (NYSE: ONTO) plummeted 31% as the company’s second-quarter guidance fell short of analysts’ expectations. Despite reporting a m ...

Bank of America downgraded Sea Limited (NYSE: SE) to Neutral from Buy in a note Friday. The bank highlighted the stock’s ...

Kohl’s Corp (NYSE: KSS) announced that board member Christine Day resigned effective May 5, 2025, stating it “was not due to ...

Thing 1 (deflationary resolution) is near-term and decisive economic death. Thing 2 (stagflationary resolution) is frogs swimming in a kettle of gently warming water.

Investing.com -- The U.S. Postal Service Board of Governors today announced the appointment of David Steiner as the 76th Postmaster General and CEO. Steiner’s appointment is pending the results of ...

The Federal Aviation Administration (FAA) reported a new outage at a Philadelphia facility that oversees air traffic at Newark Liberty airport on Friday. This is the latest in a series of equipment ...

In a recent speech at the "John Taylor and Taylor Rules in Policy" Hoover Monetary Policy Conference, Federal Reserve Governor Christopher J. Waller articulated his views on the importance of rules ...

CoreWeave’s decision to pursue significant debt financing so soon after its IPO has raised concerns among investors, prompting the drop in stock price. The move to raise debt could be interpreted as a ...

Bank of America upgraded Microchip Technology (NASDAQ: MCHP) to Neutral from Underperform on Friday. The bank cited early signs of a sales recovery, aggressive co ...

The U.S. Food and Drug Administration (FDA) today announced the approval of three new color additive petitions, expanding the range of colors from natural sources available for food manufacturers to ...

Shares of Penumbra (NYSE:PEN) rose by 5% following comments from Piper Sandler analyst Matt O’Brien, who indicated that the medical device company’s Thunderbolt product might receive regulatory ...